DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



No effect of pure oxygen inhalation on headache induced by glyceryl trinitrate.

Author(s): Daugaard D, Tfelt-Hansen P, Thomsen LL, Iversen HK, Olesen J

Affiliation(s): Department of Neurology, Danish Headache Centre, Glostrup Hospital, University of Copenhagen, Glostrup, Copenhagen, Denmark.

Publication date & source: 2010-04, J Headache Pain., 11(2):93-5. Epub 2010 Feb 9.

Publication type: Randomized Controlled Trial; Research Support, Non-U.S. Gov't

Inhalation of hyperbaric oxygen has been used as an experimental treatment for migraine and pure oxygen is an established treatment for cluster headache. Intravenous glyceryl trinitrate (GTN) is an established headache model. In the present study the possibility of decreasing the headache by inhalation of pure oxygen was explored in a double-blind crossover design in 18 healthy subjects. Inhalation of air served as placebo. The subjects received intravenous GTN (0.25 microg/kg/min) for 20 min. Headache was scored for 85 min. Sixteen of 18 (89%) subjects experienced GTN-induced headache after O(2)-inhalation and 17/18 (94%) experienced GTN-induced headache after air. The mean peak headache scores were 1.9 and 2.4, respectively, on a numerical scale of 0-10. Oxygen inhalation did not have effect on GTN-induced headache, most likely because the theoretical decrease in NO levels, due to faster metabolism of NO, is too small to be detected in the GTN headache model.

Page last updated: 2010-10-05

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017